Rational Cell Culture Optimization Enhances Experimental Reproducibility in Cancer Cells
Open accessPublished version of a preprint
Abstract
Optimization of experimental conditions is critical in ensuring robust experimental reproducibility. Through detailed metabolomic analysis we found that cell culture conditions significantly impacted on glutaminase (GLS1) sensitivity resulting in variable sensitivity and irreproducibility in data. Baseline metabolite profiling highlighted that untreated cells underwent significant changes in metabolic status. Both the extracellular levels of glutamine and lactate and the intracellular levels of multiple metabolites changed drastically during the assay. We show that these changes compromise the robustness of the assay and make it difficult to reproduce. We discuss the implications of the cells' metabolic environment when studying the effects of perturbations to cell function by any type of inhibitor. We then devised 'metabolically rationalized standard' assay conditions, in which glutaminase-1 inhibition reduced glutamine metabolism differently in both cell lines assayed, and decreased the proliferation of one of them. The adoption of optimized conditions such as the ones described here should lead to an improvement in reproducibility and help eliminate false negatives as well as false positives in these assays.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Existing recommendations that aim to increase the relevance of in vitro cultures to in vivo physiology are available for many of these factors.
“For many of these factors, existing recommendations that aim to increase the relevance of in vitro cultures to in vivo physiology are available (Baker, 2016; Muelas et al., 2018; Hirsch and Schildknecht, 2019).”
From Toward Best Practices for Controlling Mammalian Cell Culture Environments (2022) · cites this paper as Muelas et al., 2018
The Discussion (page unavailable) describes existing reporting standards and recommends documenting culture factors including cell density, medium, nutrients, and pH. It presents these measures as ways to improve reproducibility and assay evaluation, not specifically as recommendations to make in vitro cultures more representative of in vivo physiology. (LLM, conf=0.82)
Experimental — accuracy not yet measuredMedium changes have been shown to influence oxygen supply and cellular metabolism, as well as synthesis of proteins, DNA, and RNA.
“Medium changes have been shown to influence oxygen supply and cellular metabolism, as well as synthesis of proteins, DNA, and RNA (Al-Ani et al., 2018; Wright Muelas et al., 2018).”
From In Vitro research Reproducibility: Keeping up High Standards (2019) · cites this paper as Wright Muelas et al., 2018
The Results section (‘Explanation: The cellular environment is uncontrolled’; page not provided) describes changing culture-medium conditions, including glutamine depletion, that could alter cellular metabolism. The cited paper does not establish that medium changes affect oxygen supply or the synthesis of proteins, DNA, and RNA; searches for those effects found no supporting passage. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950 · see citing works
1,500 scientists lift the lid on reproducibility
Baker, M. (2016) · Nature · doi:10.1038/533452a · Cited by 4,209 · see citing works
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456 · see citing works
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · see citing works
Believe it or not: how much can we rely on published data on potential drug targets?
Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888 · see citing works
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791 · see citing works
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344 · see citing works
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328 · see citing works
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M. (2014) · Nature · doi:10.1038/nature13110 · Cited by 710 · see citing works
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · see citing works
Taylor, C. F., Field, D., Sansone, S.-A., Aerts, J., Apweiler, R., Ashburner, M., Ball, C. A., Binz, P.-A., Bogue, M., Booth, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1411 · Cited by 558 · see citing works
The Metabolomics Standards Initiative (MSI)
Fiehn, O., Robertson, D., Griffin, J., van der Werf, M., Nikolau, B., Morrison, N., Sumner, L. W., Goodacre, R., Hardy, N. W., Taylor, C., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0070-6 · Cited by 518 · see citing works
Inconsistency in large pharmacogenomic studies
Haibe-Kains, B., El-Hachem, N., Birkbak, N. J., Jin, A. C., Beck, A. H., Aerts, H. J. W. L., & Quackenbush, J. (2013) · Nature · doi:10.1038/nature12831 · Cited by 499 · see citing works
van den Heuvel, A. P. J., Jing, J., Wooster, R. F., & Bachman, K. E. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21348 · Cited by 209 · see citing works
Flagged first, then by citations
Research works printed but not linked: 32
- [2]Errington TM An open investigation of the reproducibility of cancer biology research eLife Sciences 2014 3 e04333 PMC4270077 25490932
- [4]Shoemaker RH The NCI60 human tumour cell line anticancer drug screen Nat Rev Cancer 2006 6 813 823 10.1038/nrc1951 16990858 · DOI
- [5]León Z García-Cañaveras JC Donato MT Lahoz A Mammalian cell metabolomics: Experimental design and sample preparation Electrophoresis 2013 34 2762 2775 23436493
- [6]Tritsch GL Moore GE Spontaneous decomposition of glutamine in cell culture media Experimental Cell Research 1962 28 360 364 10.1016/0014-4827(62)90290-2 13994204 · DOI
- [7]Heeneman S Deutz NEP Buurman WA The concentrations of glutamine and ammonia in commercially available cell culture media Journal of Immunological Methods 1993 166 85 91 10.1016/0022-1759(93)90331-Z 8228290 · DOI
- [8]Freshney, R. I. In Culture of Cells for Tissue Engineering 1–22, 10.1002/0471741817.ch1 (John Wiley & Sons, Inc., 2006). · DOI
- [12]Hatzis, C. et al. Enhancing reproducibility in cancer drug screening: how do we move forward? Cancer Research74, 4016–4023. PMC4119520 25015668
- [13]Haverty PM Reproducible pharmacogenomic profiling of cancer cell line panels Nature 2016 533 333 337 10.1038/nature17987 27193678 · DOI
- [16]Le A Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells Cell Metab. 2012 15 110 121 10.1016/j.cmet.2011.12.009 22225880 PMC3345194 · DOI · Paper page
- [19]DeBerardinis RJ Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis Proceedings of the National Academy of Sciences 2007 104 19345 19350 10.1073/pnas.0709747104 PMC2148292 18032601 · DOI · Paper page
- [20]Hassanein M SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival Clinical Cancer Research 2013 19 560 570 10.1158/1078-0432.CCR-12-2334 23213057 PMC3697078 · DOI
- [22]Schulze A Harris AL How cancer metabolism is tuned for proliferation and vulnerable to disruption Nat Rev Cancer 2012 491 364 373 23151579
- [23]Zhao Y Butler EB Tan M Targeting cellular metabolism to improve cancer therapeutics Cell Death Dis 2013 4 e532 10.1038/cddis.2013.60 23470539 PMC3613838 · DOI
- [24]Vander Heiden MG Targeting cancer metabolism: a therapeutic window opens Nature Reviews Drug Discovery 2011 10 671 684 10.1038/nrd3504 21878982 · DOI
- [27]Brower M Carney DN Oie HK Gazdar AF Minna JD Growth of Cell Lines and Clinical Specimens of Human Non-Small Cell Lung Cancer in a Serum-free Defined Medium Cancer Research 1986 46 798 806 3940644
- [28]Tinnemans MM S-phase arrest of nutrient deprived lung cancer cells Cytometry 1995 19 326 333 10.1002/cyto.990190407 7796697 · DOI
- [29]Ishii T Nutritional deficiency affects cell cycle status and viability in A549 cells: role of p27Kip1 Cancer Lett. 2004 213 99 109 10.1016/j.canlet.2004.03.022 15312689 · DOI
- [30]Qie S Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming Cell Cycle 2014 11 3679 3690 10.4161/cc.21944 PMC3478318 22935705 · DOI
- [31]Schneider M The importance of ammonia in mammalian cell culture Journal of Biotechnology 1996 46 161 185 10.1016/0168-1656(95)00196-4 8672289 · DOI
- [32]Huang W A proposed role for glutamine in cancer cell growth through acid resistance Cell Research 2013 23 724 727 10.1038/cr.2013.15 23357849 PMC3641590 · DOI
- [33]LaMonte G Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress Cancer Metab 2013 1 23 10.1186/2049-3002-1-23 24359630 PMC4178214 · DOI
- [34]Zinninger GF Little JB Proliferation kinetics of density-inhibited cultures of human cells, a complex invitro cell system Cancer Research 1973 33 2343 2348 4741932
- [35]Haanstra JR Targeting pathogen metabolism without collateral damage to the host Sci. Rep. 2017 7 40406 10.1038/srep40406 28084422 PMC5234033 · DOI
- [36]Haanstra JR A domino effect in drug action: from metabolic assault towards parasite differentiation Mol. Microbiol. 2011 79 94 108 10.1111/j.1365-2958.2010.07435.x 21166896 · DOI
- [37]Raamsdonk LM A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations Nat Biotechnol 2001 19 45 50 10.1038/83496 11135551 · DOI
- [38]Brazma A Minimum information about a microarray experiment (MIAME)- toward standards for microarray data Nat. Genet. 2001 29 365 371 10.1038/ng1201-365 11726920 · DOI · Paper page
- [40]Taylor CF The minimum information about a proteomics experiment (MIAPE) Nat Biotechnol 2007 25 887 893 10.1038/nbt1329 17687369 · DOI
- [43]Le Novère N Minimum information requested in the annotation of biochemical models (MIRIAM) Nat Biotechnol 2005 23 1509 1515 10.1038/nbt1156 16333295 · DOI · Paper page
- [44]Michopoulos F Targeted profiling of polar intracellular metabolites using ion-pair-high performance liquid chromatography and -ultra high performance liquid chromatography coupled to tandem mass spectrometry: Applications to serum, urine and tissue extracts Journal of Chromatography A 2014 1349 60 68 10.1016/j.chroma.2014.05.019 24861786 · DOI
- [45]Veselkov KA Optimized Preprocessing of Ultra-Performance Liquid Chromatography/Mass Spectrometry Urinary Metabolic Profiles for Improved Information Recovery Anal. Chem. 2011 83 5864 5872 10.1021/ac201065j 21526840 · DOI
- [46]Puck TT Marcus PI Cieciura SJ Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer J Exp Med 1956 103 273 284 10.1084/jem.103.2.273 13286432 PMC2136583 · DOI
- [47]Del Monte U Does the cell number 109 still really fit one gram of tumor tissue? Cell Cycle 2009 8 505 506 10.4161/cc.8.3.7608 19176997 · DOI
Cited by
Sorted by citations
In Vitro research Reproducibility: Keeping up High Standards
Hirsch, C., & Schildknecht, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01484 · Cited by 161 · see citing works
Dang, C., Harrington, K. D., Lim, Y. Y., Ames, D., Hassenstab, J., Laws, S. M., Yassi, N., Hickey, M., Rainey-Smith, S., Robertson, J., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180507 · Cited by 31 · see citing works
Toward Best Practices for Controlling Mammalian Cell Culture Environments
Klein, S. G., Steckbauer, A., Alsolami, S. M., Arossa, S., Parry, A. J., Li, M., & Duarte, C. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.788808 · Cited by 23 · see citing works
- Authors
- Wright Muelas, M., Ortega, F., Breitling, R., Bendtsen, C., & Westerhoff, H. V.
- Affiliations
- University of Manchester (GB)
- AstraZeneca (United Kingdom) (GB)
- Venue
- Scientific Reports
- Published
- 2018-02-14
- Volume
- 8
- Issue
- 1
- Pages
- 3029-3029
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5813001
- OpenAlex
- W2949384615
- Cited by
- 160
- References
- 14
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 82 · 2020: 42 · 2019: 15 · 2018: 6
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- VU Research Portal (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- AstraZeneca
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/M017702/1, 1088313)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- cell culture optimization, experimental reproducibility, cancer cells, GLS1, glutamine metabolism, lactate, intracellular metabolites, metabolite profiling, assay standardization, cell proliferation, false positives and false negatives
- MeSH terms
- Animals, Glutaminase, Glutamine, Humans, Neoplasms, Research Design, Thiadiazoles, Reproducibility of Results, Cell Culture Techniques, Cell Line, Tumor, Cell Proliferation, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review